ION?
Report
- Report Number
- 2134265-2014-02007
- Event Type
- Injury
- Date Received
- April 21, 2014
- Date of Event
- April 17, 2012
- Report Date
- March 25, 2014
- Manufacturer
- BOSTON SCIENTIFIC - MAPLE GROVE
- Product Code
- NIQ
- PMA / PMN Number
- P100023
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- NJ, US
- Reporter Occupation
- PHYSICIAN
Narratives
DEVICE IS A COMBINATION PRODUCT. DEVICE EVALUATED BY MFR.: IT IS INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION; THEREFORE, A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. A REVIEW OF THE BATCH HISTORY, HISTORICAL TRENDING, AND SIMILAR COMPLAINT TRENDING REVIEW FOR THE PRODUCT FAMILY WILL BE CONDUCTED. IF THERE IS ANY FURTHER RELEVANT INFORMATION FROM THAT REVIEW, A SUPPLEMENTAL MEDWATCH WILL BE FILED. (B)(4).
SAME CASE AS: 2134265-2014-02008. (B)(6) CLINICAL STUDY. IT WAS REPORTED THAT VESSEL SPASM OCCURRED. ON (B)(6) 2012, THE PATIENT PRESENTED DUE TO STABLE ANGINA AND WAS REFERRED FOR CARDIAC CATHETERIZATION. TARGET LESION #1 WAS A DE-NOVO LESION LOCATED IN THE MID LEFT ANTERIOR DESCENDING (LAD) EXTENDING TO DISTAL LAD WITH 90% STENOSIS AND WAS 28 MM LONG WITH A REFERENCE VESSEL DIAMETER OF 3 MM. THE LESION WAS TREATED WITH DIRECT STENT PLACEMENT USING A 2.75 MM X 32 MM ION STENT. FOLLOWING POSTDILATATION RESIDUAL STENOSIS WAS 0%. FOLLOWING STENT DEPLOYMENT AND POST-DILATION WITH A 3 MM X 15 MM QUANTUM APEX BALLOON CATHETER, SPASM OCCURRED. THE PATIENT WAS THEN TREATED WITH 225 MICROGRAMS OF INTRACORONARY NITROGLYCERIN. TEN DAYS POST PROCEDURE, THE PATIENT WAS DISCHARGED ON ASPIRIN AND PRASUGREL.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 239361 | ION? | CORONARY DRUG-ELUTING STENT | NIQ | BOSTON SCIENTIFIC - MAPLE GROVE | H7493902432270 | 14714766 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 54 YR | Required Intervention |